|
2-[(5-nitro-1H-benzimidazol-2-yl)sulfanyl]-N-[4-(trifluoromethoxy)phenyl]acetamide |
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Starkey M, et al. 2014. PLoS Pathog |
|
2-{[5-(4-chlorophenyl)-1H-imidazol-2-yl]thio}-N-(3-ethoxyphenyl)acetamide |
Depiction based on curated SMILES
N
H
Cl
N
H
3
C
S
O
N
H
O
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Starkey M, et al. 2014. PLoS Pathog |
|
3-(2-amino-1H-imidazol-5-yl)-N-heptylpropanamide |
Depiction based on curated SMILES
O
H
2
N
N
H
N
CH
3
N
H
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Ballard TE, et al. 2008. Chemistry |
|
3-(2-amino-1H-imidazol-4-yl)-N-hexyl-propionamide hydrochloride |
Depiction based on curated SMILES
ClH
NH
2
NH
N
H
3
C
O
N
H
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Ballard TE, et al. 2008. Chemistry |
|
3-(6,6-dimethyl-3-oxotetrahydro-2H-pyran-2-yl)-3-hydroxy-1,3-dihydro-2H-indol-2-one |
Depiction based on curated SMILES
O
N
H
O
CH
3
OH
O
CH
3
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
von Ambüren J, et al. 2020. Microorganisms |
|
3-hydroxy-3-[2-oxo-2-(pyridin-4-yl)ethyl]-1,3-dihydro-2H-indol-2-one |
Depiction based on curated SMILES
OH
N
O
HN
O
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
von Ambüren J, et al. 2020. Microorganisms |
|
1H-Indole, 3-(2-pyridin-4-yl-thiazol-4-yl)- |
Depiction based on curated SMILES
N
N
S
HN
|
Pseudomonas Yersinia |
TTSS (Type III secretion system) TTSS (Type III secretion system) |
Preclinical (in vitro) Preclinical (in vitro) |
Harmon DE, et al. 2010. Antimicrob Agents Chemother
|
|
4-fluoro-N-[4-(1-hydroxy-6-nitrobenzimidazol-2-yl)phenyl]benzamide |
Depiction based on curated SMILES
O
F
OH
N
_
O
O
+
N
N
N
H
|
Pseudomonas |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Marsden AE, et al. 2016. Antimicrob Agents Chemother |
|
5-[3-(4-hexyltriazol-1-yl)propyl]-1H-imidazol-2-amine;hydrochloride |
Depiction based on curated SMILES
N
ClH
H
2
N
NH
N
CH
3
N
N
|
Pseudomonas |
Biofilm |
Preclinical (in vitro) |
Ballard TE, et al. 2008. Chemistry |
|
furo[3,2-b]quinoxalin-3-yl-(4-phenylpiperazin-1-yl)methanone |
Depiction based on curated SMILES
N
N
N
O
N
O
|
Pseudomonas |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Harmon DE, et al. 2010. Antimicrob Agents Chemother |
|
| | |